RUBICON RESEARCH LIMITED Share Price

NSE: RUBICON
|
Pharmaceuticals

₹ 1,508.60

+₹31.50 (2.13%)
1D
Last updated 16 Oct, 2026, 15:54 IST

RUBICON RESEARCH LIMITED Share Price Today

As of 17 Oct 2026, RUBICON RESEARCH LIMITED share price is ₹1,508.60. The stock opened at ₹1,477.10, compared to its previous close of ₹1,477.10. During today's trading session, RUBICON RESEARCH LIMITED share price moved in the range of ₹1,468.00 to ₹1,544.90, with an average price of ₹1,506.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹570.75 and a high of ₹1,899.00. On the performance front, RUBICON RESEARCH LIMITED share price has increased by 73.28% over the last six months and is up 140.15% on a year-on-year basis.

₹1,468.00
2.13% up today
₹1,544.90
1D LOW
1D HIGH

RUBICON RESEARCH LIMITED Returns Calculator

Volume
2,12,955
Average traded price
₹1,515.08
Last traded time
03:54:46 16 Oct
Last traded quantity
6
Circuit
L
H
₹1,206.90
₹1,810.30
52-week
L
H
₹570.75
₹1,899.00
Mkt Cap Cr
25,016.01
P/E
86.8
P/B
19.41
ROA
12.39%
ROE
19.14%
ROCE
22.56%
Quick Ratio
1.14
EV/EBITDA
52.73
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Rubicon Research has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Rubicon Research appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Rubicon Research revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,426.9134.855.0511.19%13.74%17.33%2.3121.47
Divis Laboratories2,39,982.2783.6814.614.6%15.32%19.56%3.554.39
Torrent Pharmaceuticals1,73,447.7480.4520.634.87%25.49%13.85%0.7537.55
Zydus Lifesciences1,12,149.3624.424.148.57%18.59%17.35%0.9115.14
Laurus Labs1,09,143.07102.0320.9910.38%16.77%16.14%0.6853.4
Cipla1,07,745.7031.93.117.92%11.27%14.95%2.518.2
Dr. Reddy's Laboratories1,02,820.0932.32.75.48%11.07%12.54%1.3516.14
Mankind Pharma97,263.8645.455.767.36%11.74%13.13%0.7425.49
Aurobindo Pharma95,512.7325.742.526.34%9.25%11.76%1.1512.36
Lupin89,436.7716.113.9814.47%23.76%24.88%1.429.68

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About RUBICON RESEARCH LIMITED

ISIN
INE506V01022
Sector Market Cap
₹ 25,016.01 Cr

Rubicon Research Ltd is an India-based pharmaceutical formulations company, which is focused on research and development, with a portfolio of specialty products and drug-device combination products targeting regulated markets, and particularly the United States. Its portfolio spans multiple dosage forms, including oral solids, oral liquids, nasal, and topical. Its technologies include RubiReten and RubiSRL. Its services include intellectual property evaluation and product design, formulation research development, analytical research development, technology transfer, dossier compilation and regulatory support, and clinical trials supplies. Its products are spread across many therapeutic areas, such as Analgesics/Pain Management, CVS, CNS, Hypokalemia, Skeletal Muscle Relaxants, NRT, Gastrointestinal, Metabolic, Immunosuppressant, and others. Others include Antipyretic, Hormonal Products, Diuretic, Antimuscarinics, Oral Rehydration Therapy, Over the Counter products, and Respiratory.

RUBICON RESEARCH LIMITED Financial Highlights

  • Revenue: RUBICON RESEARCH LIMITED reported revenue of ₹1,761.69 crore in FY26 vs ₹1,287.90 crore in FY25. It showed an increase of 36.79% on a yearly basis.
  • Operating Profit: RUBICON RESEARCH LIMITED reported an operating profit of ₹320.53 crore in FY26 vs ₹194.52 crore in FY25. It showed an increase of 64.78% on a year-on-year basis.
  • Net Profit: RUBICON RESEARCH LIMITED reported a net profit of ₹246.74 crore in FY26 vs ₹134.36 crore in FY25. It showed an increase of 83.64% on a yearly basis.

RUBICON RESEARCH LIMITED Quarterly Result Highlights

  • RUBICON RESEARCH LIMITED reported revenue of ₹540.02 crore in Jun 2026, compared with ₹516.53 crore in Mar 2026, representing an increase of 4.55% on a quarter-on-quarter (QoQ) basis.
  • RUBICON RESEARCH LIMITED reported an operating profit of ₹110.37 crore in Jun 2026, compared with ₹98.69 crore in Mar 2026, representing an increase of 11.84% on a quarter-on-quarter (QoQ) basis.
  • RUBICON RESEARCH LIMITED reported a profit of ₹84.78 crore in Jun 2026, compared with ₹76.79 crore in Mar 2026, reflecting an increase of 10.41% on a QoQ basis.
  • The earnings per share (EPS) of RUBICON RESEARCH LIMITED stood at ₹15.52 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
59.76%
FII
7.52%
Other DII
2.20%
Retail and other
23.30%
Mutual funds
7.23%
Foreign Institutional Investor (FII)
FII shareholding by period
Oct 20259.37%
Dec 20258.00%
Mar 20267.54%
Jun 20267.52%
1 day
+2.13%
1 week
-2.58%
1 month
-14.61%
1 year
+140.15%
3 years
+140.15%
5 years
+140.15%
Day
Open / Close
Change %
16 Oct 26
₹1,477.10 / ₹1,508.60
+2.13%
15 Oct 26
₹1,517.50 / ₹1,477.10
-3.12%
14 Oct 26
₹1,513.90 / ₹1,524.70
+0.09%
13 Oct 26
₹1,540.20 / ₹1,523.40
-1.09%
Show more

RUBICON RESEARCH LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,753.96₹1,284.27₹853.89₹393.52
Other Income₹7.73₹3.63₹18.50₹25.48
Total Revenue₹1,761.68₹1,287.91₹872.39₹419.00
Total Expenses₹1,441.15₹1,093.38₹769.53₹430.05
Profit Before Tax₹320.53₹194.52₹102.86-₹11.05
Tax₹73.80₹60.16₹11.85₹5.84
Profit After Tax₹246.74₹134.36₹91.01-₹16.89
EPS - Basic₹15.52₹8.82₹5.98-₹1.11
EPS - Diluted₹15.31₹8.68₹5.91-₹1.11

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹320.53₹194.52₹102.86-₹11.05
Income before WC changes₹428.15₹287.93₹174.17₹35.18
Change in Assets-₹381.28-₹244.21-₹241.49-₹162.98
Change in Liabilities₹266.68₹154.21₹106.40₹54.87
Change in WC-₹114.60-₹90.00-₹135.08-₹108.11
Cash flow from Operations₹205.05₹159.18₹21.01-₹74.75
Cash flow from Investing-₹409.72-₹64.81-₹68.51-₹33.82
Cash flow from Financing₹283.07-₹39.81₹43.55₹122.81
Total Cash Flow₹78.39₹54.56-₹3.95₹14.24
Cash (Start of the year)₹104.98₹50.60₹54.43₹38.67
Cash (End of the year)₹185.65₹104.98₹50.61₹54.43

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹644.91₹388.07₹346.32₹248.12
Current Assets₹1,681.81₹1,063.37₹763.17₹501.59
Total Assets₹2,326.71₹1,451.43₹1,109.49₹749.70
Current Liabilities₹835.87₹786.03₹572.50₹361.32
Net Current Asset₹845.94₹277.34₹190.67₹140.27
Non-Current Liabilities₹202.03₹124.42₹151.99₹102.01
Equity Capital₹1,288.82₹540.99₹385.00₹286.38
Total Equity & Liabilities₹2,326.71₹1,451.43₹1,109.49₹749.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,306.08₹1,073.84₹630.51₹393.52
Other Income₹10.83₹19.68₹26.43₹25.48
Total Revenue₹1,316.91₹1,093.52₹656.94₹419.00
Total Expenses₹1,064.14₹870.24₹622.87₹430.05
Profit Before Tax₹252.78₹223.28₹34.07-₹11.05
Tax₹64.61₹55.74₹9.73₹5.84
Profit After Tax₹188.17₹167.54₹24.35-₹16.89
EPS - Basic₹11.83₹11.00₹1.60-₹1.11
EPS - Diluted₹11.67₹10.82₹1.58-₹1.11

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹252.78₹223.28₹34.07-₹11.05
Income before WC changes₹328.41₹291.63₹85.60₹35.18
Change in Assets-₹292.10-₹331.90-₹15.99-₹162.98
Change in Liabilities₹96.60₹96.78₹29.47₹54.87
Change in WC-₹195.49-₹235.12₹13.49-₹108.11
Cash flow from Operations₹38.71₹29.65₹83.20-₹74.75
Cash flow from Investing-₹271.79-₹10.03-₹130.49-₹33.82
Cash flow from Financing₹296.72-₹34.05₹45.86₹122.81
Total Cash Flow₹63.64-₹14.43-₹1.42₹14.24
Cash (Start of the year)₹25.85₹40.47₹41.76₹38.67
Cash (End of the year)₹91.78₹25.85₹40.47₹54.43

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹561.00₹390.61₹446.09₹248.12
Current Assets₹1,414.50₹950.32₹570.51₹501.59
Total Assets₹1,975.50₹1,340.94₹1,016.60₹749.70
Current Liabilities₹456.82₹588.54₹431.25₹361.32
Net Current Asset₹957.69₹361.78₹139.26₹140.27
Non-Current Liabilities₹165.42₹84.61₹109.48₹102.01
Equity Capital₹1,353.27₹667.79₹475.87₹286.38
Total Equity & Liabilities₹1,975.50₹1,340.94₹1,016.60₹749.70
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1508.6
5
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 5
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
34.12
Neutral
ATR (14)
62.02
Neutral
STOCH(9,6)
35.98
Neutral
STOCH RSI (14)
47.8
Neutral
ADX(9)
46.67
Bearish
UO(9)
48.34
Neutral
ROC(12)
-6.24
Bearish
WillR(14)
-75.32
Neutral
Period
Simple value
Exponential vaue
5D
1514.8
1515.55
10D
1543.88
1543.98
20D
1603.65
1593.6
50D
1691.21
1613.78
100D
1530.07
1501.33
Volume trend — traded volume by day
16 Oct2L
15 Oct3L
14 Oct1L
13 Oct1L
12 Oct1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
RUBICON RESEARCH LIMITED
Pharmaceuticals
Add Stock
Add Another

RUBICON RESEARCH LIMITED Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.